Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Salarius Pharmaceuticals, Inc. (FLKS) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/10/2023 8-K Quarterly results
Docs: "Salarius Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides a Business Update FDA removed partial clinical hold for Ewing sarcoma Phase 1/2 study with seclidemstat"
07/12/2023 8-K Quarterly results
05/16/2023 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events, Financial Statements and E...
Docs: "SERIES [A-1/A-2] COMMON STOCK PURCHASE WARRANT SALARIUS PHARMACEUTICALS, INC.",
"PRE-FUNDED COMMON STOCK PURCHASE WARRANT SALARIUS PHARMACEUTICALS, INC.",
"PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT SALARIUS PHARMACEUTICALS, INC.",
"SECURITIES PURCHASE AGREEMENT",
"REGISTRATION RIGHTS AGREEMENT",
"Salarius Pharmaceuticals Announces $6 Million Private Placement Priced At-the-Market Under Nasdaq Rules",
"Salarius Pharmaceuticals Announces Closing of $6 Million Private Placement Priced At-the-Market Under Nasdaq Rules"
03/13/2023 8-K Other Events  Interactive Data
01/10/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Salarius Pharmaceuticals Announces Issuance of New U.S. Patent for Next-Generation Targeted Protein Degraders Expands intellectual property portfolio with composition-of-matter patent protection for second novel molecular glue"
12/01/2022 8-K Quarterly results
11/10/2022 8-K Quarterly results
11/03/2022 8-K Quarterly results
10/27/2022 8-K Quarterly results
10/18/2022 8-K Other Events  Interactive Data
Docs: "Salarius Pharmaceuticals Announces Pause in New Patient Enrollment in its Phase 1/2 Trial of Seclidemstat in Ewing Sarcoma and FET-Rearranged Sarcomas"
10/14/2022 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits  ...
Docs: "CERTIFICATE OF AMENDMENT TO THE RESTATED CERTIFICATE OF INCORPORATION",
"Salarius Pharmaceuticals Announces 1-for-25 Reverse Stock Split"
08/03/2022 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Salarius Pharmaceuticals and VolitionRx Enter into R&D Collaboration Agreement"
06/17/2022 8-K Quarterly results
05/12/2022 8-K Quarterly results
04/26/2022 8-K Other Events, Financial Statements and Exhibits  Interactive Data
04/22/2022 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events, Financial Statements and E...
Docs: "COMMON STOCK PURCHASE WARRANT SALARIUS PHARMACEUTICALS, INC.",
"SECURITIES PURCHASE AGREEMENT",
"VOTING AGREEMENT",
"Salarius Pharmaceuticals, Inc. Announces $2.3 Million Registered Direct Offering"
04/01/2022 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits  ...
Docs: "AMENDMENT TO AMENDED AND RESTATED BYLAWS OF"
03/10/2022 8-K Quarterly results
01/13/2022 8-K Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits  Inte...
Docs: "ACQUISITION AND STRATEGIC COLLABORATION AGREEMENT",
"Salarius Pharmaceuticals Expands Oncology Pipeline Through Strategic Acquisition of Targeted Protein Degradation Portfolio from DeuteRx, LLC Conference call and live audio webcast scheduled for today at 8:30 a.m. EST"
11/19/2021 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing  Interact...
09/16/2021 8-K Quarterly results
08/20/2021 8-K Quarterly results
08/05/2021 8-K Quarterly results
Docs: "Salarius Pharmaceuticals Reports Second Quarter 2021 Financial Results and Highlights Recent Company Progress Clinical Trial in Hematologic Cancers Initiated and Initial Patients Enrolled in Expanded Sarcoma Clinical Trial&#59; Multiple Potential Data Readouts Expected in 2021 and 2022"
07/02/2021 8-K Quarterly results
07/01/2021 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "COMMON STOCK PURCHASE WARRANT SALARIUS PHARMACEUTICALS, INC.",
"Hogan Lovells US LLP"
06/16/2021 8-K Quarterly results
05/20/2021 8-K Quarterly results
05/12/2021 8-K Quarterly results
03/08/2021 8-K Quarterly results
03/03/2021 8-K Quarterly results
02/17/2021 8-K Quarterly results
02/05/2021 8-K Quarterly results
01/21/2021 8-K Other Events
12/11/2020 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Material Modifications to Rights of Secu...
Docs: "Form of Inducement Warrant",
"Form of Inducement Letter"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy